Shareholders meeting

Date: October 01, 2026 National Stock Exchange of India Limited Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051 NSE Symbol: QMSMEDI Subject: Summary of Proceedings of the 09th Annual General Meeting (AGM) of QMS Medical Allied Services Limited held on Wednesday, September 30, 2026. Dear Sir / Madam, Pursuant to Regulation 30 read with Para A of Part A of Schedule III to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the summary of proceedings of the 09th Annual General Meeting (“AGM”) of the Company held on Wednesday, September 30, 2026 at 02.30 P.M. (IST) through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”). The AGM concluded at 02.51 P.M. (IST). The summary of proceedings is also being made available on the website of the Company at https://qmsmas.com/. You are requested to take the same on record. Thanking you, Yours faithfully, For QMS Medical Allied Services Limited Mrs. Toral Jailesh Bhadra Company Secretary and Compliance Officer Membership No.: A56927 Encl.: As above CIN: L33309MH2017PLC299748; Email id: mm@qmsmas.com SUMMARY OF PROCEEDINGS OF THE 09TH ANNUAL GENERAL MEETING OF QMS MEDICAL ALLIED SERVICES LIMITED 1. Date, time and mode of the meeting The 09th Annual General Meeting of the Members of QMS Medical Allied Services Limited (“the Company”) was held on Wednesday, September 30, 2026 commencing at 02.30 p.m. (IST), through VC / OAVM, in accordance with the provisions of the Companies Act, 2013 (“the Act”) and the General Circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. The deemed venue of the meeting was the Registered Office of the Company at A1 A2/B1 B2, Navkala Bharti Bldg Plot No16 Prabhat Colony opp near Santacruz Bus depot Santa Cruz East, Mumbai City, Mumbai, Maharashtra, India, 400055. 2. Directors, Key Managerial Personnel and invitees present The following Directors attended the meeting through VC: Sr. Name Designation Attended from 1 Mr. Mahesh Pahalraj Makhija Chairman and Managing Director Registered Office, Mumbai 2 Mr. Prajwal Jayasheela Independent Director; Mira Road, Poojari Chairperson – Audit Committee Mumbai and Stakeholders’ Relationship Committee 3 Mr. Niken Ravin Shah Independent Director; Chairman – Fort, Mumbai Nomination and Remuneration Committee and CSR Committee 4 Mr. Deena Nath Pathak Non-Executive Non-Independent Chanakyapuri, Director Delhi 5 Mr. Pranav Manhar Badheka Additional Independent Director Wadala, Mumbai 6 Mrs. Sarita Vijay Mahajan Independent Director Ghatkopar, Mumbai The following Key Managerial Personnel and invitees were also present: • Mrs. Toral Bhadra – Company Secretary and Compliance Officer • Ms. Sejal Vivek Mhatre – Chief Financial Officer • Mr. Harsh Dedhia, M/s. H. H. Dedhia & Associates, Chartered Accountants – Statutory Auditors • M/s. Maharshi Ganatra & Associates, Company Secretaries – Secretarial Auditors; Mr. Maharshi Ganatra – Scrutinizer • M/s. Khushbu Parekh & Co. – Internal Auditors 3. Chairman and quorum CIN: L33309MH2017PLC299748; Email id: mm@qmsmas.com Mr. Mahesh Pahalraj Makhija, Chairman and Managing Director, chaired the meeting. 24 Members were present through VC. The requisite quorum being present, the Company Secretary informed the Members that the meeting was validly constituted. The attendance of Members through VC was reckoned for the purpose of quorum under Section 103 of the Act. 4. Opening remarks by the Company Secretary The Company Secretary welcomed the Members, Directors, Auditors, Scrutinizer and other invitees, introduced the Directors present, and informed the Members that: • as the meeting was held through VC, physical attendance of Members had been dispensed with and the facility of appointing proxies was not available; • the deemed venue of the meeting was the Registered Office of the Company; • the proceedings of the meeting were being recorded for compliance purposes; • the statutory registers required under the Act were available for inspection as stated in the Notice; • the facility of e-Voting was provided through remote e-Voting and e-Voting during the meeting, and Members who had voted through remote e-Voting were not entitled to vote again at the meeting; and • two Members had registered themselves as speaker shareholders. 5. Chairman’s address The Chairman welcomed the Members and addressed them. The key points of the address were: • Standalone performance for FY 2025-26: revenue of ₹152.30 crore (FY 2024-25: ₹144.87 crore), growth of about 5.1%; EBITDA of ₹20.50 crore (FY 2024-25: ₹23.32 crore); net profit of ₹6.69 crore (FY 2024-25: ₹10.42 crore). • Consolidated performance for FY 2025-26, including Saarathi Healthcare Private Limited: revenue of ₹172.88 crore (FY 2024-25: ₹156.01 crore), growth of about 10.8%; EBITDA of ₹25.88 crore (FY 2024-25: ₹25.60 crore); net profit of ₹11.92 crore (FY 2024-25: ₹13.70 crore). • The Board has recommended a final dividend of 5%, i.e. ₹0.50 per equity share, for FY 2025- 26, subject to approval of the Members. • The Products business has a portfolio of more than 900 SKUs, and the Healthcare Services business conducted 32,380 healthcare camps across India during FY 2025-26. • Strategic developments during the current year: migration from NSE Emerge to the NSE Mainboard in June 2026; acquisition of the remaining stake in Saarathi Healthcare, making it a wholly owned subsidiary; and the proposed Composite Scheme involving the Company, Health Care at Home India and Saarathi Healthcare, subject to the necessary statutory, regulatory and shareholder approvals. • On 27 August 2026, the Company signed a five-year exclusive marketing and distribution agreement with HEINE Optotechnik, Germany, under which the Company will be the sole distributor in India for the covered HEINE portfolio from 1 January 2027 to 31 December 2031. CIN: L33309MH2017PLC299748; Email id: mm@qmsmas.com • The proposed investment in BeamOptics Scientific and the continued expansion of the Company’s consumer healthcare brand, Q Devices. 6. Notice, reports and e-Voting The Notice of the AGM and the Annual Report for FY 2025-26 had been sent by electronic mode to Members whose e-mail addresses are registered with the Company, the Registrar and Share Transfer Agent or the Depositories, and were also available on the website of the Company and of the Stock Exchange. The Notice convening the meeting was taken as read. The Company Secretary informed the Members that the Independent Auditors’ Reports on the Financial Statements and the Secretarial Audit Report for FY 2025-26 were unqualified and did not contain any qualification, reservation, adverse remark or modified opinion. The Company had engaged National Securities Depository Limited (NSDL) to provide remote e- Voting and e-Voting during the meeting. The remote e-Voting period commenced on Sunday, 27 September 2026 at 9:00 a.m. (IST) and ended on Tuesday, 29 September 2026 at 5:00 p.m. (IST). The Board had appointed Mr. Maharshi Ganatra of M/s. Maharshi Ganatra & Associates, Company Secretaries, as the Scrutinizer to scrutinise the e-Voting process in a fair and transparent manner. 7. Business transacted The following items of business, as set out in the Notice of the AGM, were taken up and put to vote through remote e-Voting and e-Voting at the meeting: Item Particulars Type of resolution Ordinary Business 1 Adoption of the Standalone Audited Financial Statements of Ordinary the Company for the financial year ended 31 March 2026, together with the Reports of the Board of Directors and Auditors thereon 2 Adoption of the Consolidated Audited Financial Statements of Ordinary the Company for the financial year ended 31 March 2026, together with the Report of the Auditors thereon 3 Re-appointment of Mr. Mahesh Pahalraj Makhija, who retires Ordinary by rotation and, being eligible, offers himself f [Showing first 8,000 characters — download PDF for full document]